Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2041
Global Prevalence and Clinical Outcomes of Cogan Syndrome
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2141
Glucocorticoid Therapy-Associated Bone Fractures Are Associated with Osteoporosis Underscreening in Patients with Rheumatoid Arthritis
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2486
Glucocorticoids May Mitigate the Risk of Avacopan-Induced Liver Dysfunction in ANCA-Associated Vasculitis: Data from a Multicenter Observational Study in Japan
Vasculitis – ANCA-Associated Poster III- 10:30AM-12:30PM
-
Abstract Number: 1812
Glycosylation Changes as Non-Invasive Biomarkers for Lupus Nephritis Detection and Prognosis
SLE – Etiology & Pathogenesis Poster- 10:30AM-12:30PM
-
Abstract Number: 2006
Gout Flares After Stopping Anti-inflammatory Prophylaxis During the Early Phases of Urate-Lowering Therapy
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 1992
Gout FlaresFollowingImmune Checkpoint Inhibitors Treatment
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 1996
Granulomatous Reactions in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Literature Review
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 1912
Greater Glucocorticoid and Less Biologic/Targeted Therapy Use in Midwest PsA Patients Despite Prevalent Comorbidity
Healthcare Disparities in Rheumatology Poster III- 10:30AM-12:30PM
-
Abstract Number: 2204
Guidance for Stem Cell Therapy for Juvenile Systemic Sclerosis Patients
Pediatric Rheumatology – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2342
Guselkumab Shows Similar Domain-Specific Efficacy in Females and Males with Active Psoriatic Arthritis: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2335
Hand Function and Development of Psoriatic Arthritis in Skin Psoriasis Patients, a Prospective Cohort Study
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 1969
Harmonising Consensus and Reliability Studies in Musculoskeletal Ultrasound
Imaging of Rheumatic Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1913
Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review
Healthcare Disparities in Rheumatology Poster III- 10:30AM-12:30PM
-
Abstract Number: 1931
Health System Improvement in Appropriate Test Utilization Involving ANA Testing in the Inpatient and Outpatient Setting
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 2015
Health-Related Quality of Life in Patients with Gout Receiving Treat-to-Target Urate-Lowering Therapy